Nrx pharmaceuticals to present at 8th annual dawson james conference

Radnor, pa. , oct. 5, 2023 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced that dr. jonathan javitt, chief scientist of nrx pharmaceuticals, will present a corporate overview at the 8th annual dawson james conference on thursday, october 12th, 2023, at the wyndam grand jupiter at harbourside place, in jupiter florida.
NRXP Ratings Summary
NRXP Quant Ranking